Related Experiment Video

Updated: May 4, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.4K

S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16

S-Y Xu1, F Wang1, G Wei1

  • 1Department of Gastroenterology, Renmin Hospital, Hubei University of Medicine, Shiyan, China.

Cancer Gene Therapy
|December 17, 2013
PubMed

Insights

S-phase kinase-associated protein 2 (Skp2) is crucial for colorectal cancer growth. Inhibiting Skp2 blocks tumor cell proliferation and survival by regulating cell cycle proteins p16 and p27.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Colorectal cancer (CRC) remains a significant global health challenge.
  • Understanding the molecular mechanisms driving CRC proliferation and survival is critical for developing targeted therapies.

Purpose of the Study:

  • To elucidate the role and mechanism of S-phase kinase-associated protein 2 (Skp2) in colorectal cancer cell proliferation and survival.
  • To investigate Skp2's impact on the cell cycle and its regulation of key cell cycle proteins.

Main Methods:

  • Utilized adenoviral vectors for Skp2 short hairpin RNA (shRNA) knockdown in SW480 colorectal cancer cells.
  • Assessed cell cycle progression and apoptosis using Flow Cytometry and TdT-mediated dUTP nick-end labeling (TUNEL) staining.
  • Evaluated cell proliferation via MTT assay and protein expression of p16 and p27 using Western blot.
  • Investigated in vivo tumor growth inhibition and apoptosis in a human colorectal cancer xenograft mouse model.

Main Results:

  • Knockdown of Skp2 significantly inhibited SW480 cell proliferation and induced apoptosis in vitro.
  • Skp2 blockade was essential for G1/S phase cell cycle progression.
  • In vivo, Skp2 inhibition suppressed tumor growth and promoted tumor cell apoptosis.
  • Skp2 was found to regulate the expression of cell cycle inhibitors p16 and p27.

Conclusions:

  • Skp2 plays a critical role in promoting colorectal cancer cell proliferation and survival.
  • Targeting Skp2 inhibits colorectal cancer growth by downregulating p16 and p27 expression, impacting cell cycle progression.

More Related Videos

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

10.4K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

10.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.4K